Eran Ophir

Eran Ophir

Tel Aviv District, Israel
2K followers 500+ connections

Join to view profile

About

I was appointed Chief Scientific Officer at Compugen in May 2023. In my role, I’m…

Articles by Eran

Activity

Join now to see all activity

Experience

  • Compugen Graphic

    Compugen

    Israel

  • -

  • -

    Israel

  • -

  • -

    Holon, Tel Aviv District, Israel

  • -

    Holon Area, Israel

  • -

    Holon, Tel Aviv District, Israel

  • -

    Israel

  • -

    Israel

  • -

    Lausanne Area, Switzerland

  • -

    Israel

  • -

  • -

Education

  • Weizmann Institute of Science Graphic

    Weizmann Institute of Science

    -

    Developed cell therapy for the induction of tolerance to Bone-Marrow Transplantation and eliminating hematological malignancies.

    - Received the Haim Holtzman Prize for my PhD

  • -

    • Graduated Magna Cum Laude in Computer Science

    • Graduated Summa Cum Laude in Biology

Publications

Patents

  • Anti third party central memory central memory T cells, methods of producing same and use same in transplantation and disease treatment

    Issued US20180193384A1

    The present invention, relates to non-GVHD inducing anti-third party cells comprising central memory T-lymphocyte phenotype. It relates to their generation and use in transplantation and in disease treatment.

    Other inventors
    • Yair Reiner
    • Yaki Eidelstein
    • Esti bachar-lusting

  • Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment

    Issued US 61/380,716

    The present invention relates to non-graft versus host disease (GVHD) inducing anti-third party cells comprising a central memory T-lymphocyte phenotype and to their use for graft versus leukemia/lymphoma treatment.

    Other inventors
    • Assf Lask
    • Noga Or-Geva
    • Adva Cohen
    • Yair Reisner

  • Triple combination antibody therapies

    Issued US11225523B2

    he present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies

    Other inventors

  • GENETICALLY MODIFIEDANTI-THIRD PARTY CENTRAL MEMORY T CELLS AND USE OF SAME IN IMMUNOTHERAPY

    Issued US202/08034A1

    An isolated cell having a central memory T-lymphocyte (Tcm) phenotype, the cell being tolerance-inducing cell and capable of homing to the lymph nodes following transplantation, the cell being transduced to express a cell surface receptor comprising a T cell receptor signaling module is disclosed. Methods of generating same and using same are also disclosed.

    Other inventors

  • Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof

    Issued US10124061B2

    Other inventors

Honors & Awards

  • The Haim Holtzman Memorial Prize in recognition of Scientific accomplishments

    -

  • Katzir Travell Fellowship

    -

  • The Weizmann Institute of Science Dean's prize in recognition of academic excellence and scientific accomplishments

    -

  • Graduated B.Sc. with honors

    -

  • Excellence Memorial Scholarship

    -

  • Excellence Memorial Scholarship

    -

  • Manny Foundation Excellence Award

    -

Recommendations received

1 person has recommended Eran

Join now to view

More activity by Eran

View Eran’s full profile

  • See who you know in common
  • Get introduced
  • Contact Eran directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses

See all courses